These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Recurrent genital herpes suppressed by oral acyclovir: a multicentre double blind trial. Thin RN; Jeffries DJ; Taylor PK; Ayra OP; Rodin P; Yeo J; Fiddian AP J Antimicrob Chemother; 1985 Aug; 16(2):219-26. PubMed ID: 3905750 [TBL] [Abstract][Full Text] [Related]
17. Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromes. Sacks SL; Fox R; Levendusky P; Stiver HG; Roland S; Nusinoff-Lehrman S; Keeney R Sex Transm Dis; 1988; 15(1):58-62. PubMed ID: 3282336 [TBL] [Abstract][Full Text] [Related]
18. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. Bryson YJ; Dillon M; Lovett M; Acuna G; Taylor S; Cherry JD; Johnson BL; Wiesmeier E; Growdon W; Creagh-Kirk T; Keeney R N Engl J Med; 1983 Apr; 308(16):916-21. PubMed ID: 6339923 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV. Warren T; Harris J; Brennan CA Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]